Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development

dc.contributor.authorCeci, Ludovica
dc.contributor.authorZhou, Tianhao
dc.contributor.authorLenci, Ilaria
dc.contributor.authorMeadows, Vik
dc.contributor.authorKennedy, Lindsey
dc.contributor.authorLi, Ping
dc.contributor.authorEkser, Burcin
dc.contributor.authorMilana, Martina
dc.contributor.authorZhang, Wenjun
dc.contributor.authorWu, Chaodong
dc.contributor.authorSato, Keisaku
dc.contributor.authorChakraborty, Sanjukta
dc.contributor.authorGlaser, Shannon S.
dc.contributor.authorFrancis, Heather
dc.contributor.authorAlpini, Gianfranco
dc.contributor.authorBaiocchi, Leonardo
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2023-05-16T13:47:36Z
dc.date.available2023-05-16T13:47:36Z
dc.date.issued2022
dc.description.abstractThe poor prognosis of cholangiocarcinoma in humans is related to several factors, such as (i) the heterogeneity of the disease, (ii) the late onset of symptoms and (iii) the limited comprehension of the carcinogenic pathways determining neoplastic changes, which all limit the pursuit of appropriate treatment. Several risk factors have been recognized, including different infective, immune-mediated, and dysmorphogenic disorders of the biliary tree. In this review, we report the details of possible mechanisms that lead a specific premalignant pathological condition to become cholangiocarcinoma. For instance, during liver fluke infection, factors secreted from the worms may play a major role in pathogenesis. In primary sclerosing cholangitis, deregulation of histamine and bile-acid signaling may determine important changes in cellular pathways. The study of these molecular events may also shed some light on the pathogenesis of sporadic (unrelated to risk factors) forms of cholangiocarcinoma, which represent the majority (nearly 75%) of cases.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationCeci L, Zhou T, Lenci I, et al. Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development. Cancers (Basel). 2022;14(6):1442. Published 2022 Mar 11. doi:10.3390/cancers14061442en_US
dc.identifier.urihttps://hdl.handle.net/1805/33011
dc.language.isoen_USen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.3390/cancers14061442en_US
dc.relation.journalCancersen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectBile duct cystsen_US
dc.subjectCholangiocarcinomaen_US
dc.subjectCirrhosisen_US
dc.subjectLiver flukeen_US
dc.subjectPrimary sclerosing cholangitisen_US
dc.subjectRisk factoren_US
dc.titleMolecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Developmenten_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
cancers-14-01442.pdf
Size:
677.19 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: